Publications
Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. Health policy (Amsterdam, Netherlands)Health Policy. 2010;97(2-3):122-129.
Registration for public drug benefits across areas of differing ethnic composition in British Columbia, Canada. BMC health services researchBMC Health Serv.Res.. 2010;10:171.
Sex, drugs and gender roles: mapping the use of sex and gender based analysis in pharmaceutical policy research. International journal for equity in healthInt.J.Equity Health.. 2010;9:26.
BC Rx Atlas 2nd Edition (2009). 2nd Edition. Centre for Health Services and Policy Research, University of British Columbia; 2009.
Breadth, Depth and Agreement Among Provincial Drug Formularies in Canada . Healthcare Policy. 2009;4(4):e162-e184.
Breadth, Depth and Agreement among Provincial Formularies in Canada. Healthcare policy = Politiques de santeHealthc.Policy.. 2009;4(4):e162-84.
British Columbia Medical and Hospital Atlas. Vancouver (BC): UBC Centre for Health Services and Policy Research; 2009.
Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Social science & medicine (1982)Soc.Sci.Med.. 2009;68(5):919-924.
Chronic Catastrophes: Exploring the Concentration & Sustained Nature of Ambulatory Rx Drug Expenditures in the Population of BC. Social Science and Medicine. 2009.
Comparing tiered formularies and reference pricing policies: A systematic review. Open Medicine. 2009;3(3).
Cost-Related Prescription Nonadherence in the United States and Canada. Clinical Therapeutics. 2009;31(1):213-219.
Open access archiving and article citations within health services and policy research. Journal of the Canadian Health Libraries Association. 2009;30(2):51-58.
Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. The Open Health and Policy Journal. 2009;2:1-9.
Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. Health policy (Amsterdam, Netherlands)Health Policy. 2008;87(2):133-145.
Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Health economicsHealth Econ.. 2008;17(12):1379-1392.
On the validity of area-based income measures to proxy household income. BMC health services researchBMC Health Serv.Res.. 2008;8:79.
Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatric services (Washington, D.C.)Psychiatr.Serv.. 2007;58(1):79-84.
Direct-to-consumer advertising and expenditures on prescription drugs: a comparison of experiences in the United States and Canada. Open medicine : a peer-reviewed, independent, open-access journalOpen Med.. 2007;1(1):e37-45.
Influencing Drug Prices through Formulary-Based Policies: Lessons from New Zealand. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):e121-40.
Pharmaceutical use and outcomes: always a need for a sober second look. Healthcare policy = Politiques de santeHealthc.Policy.. 2007;3(1):10-22.
A population-based analysis of statin utilization in British Columbia. Clinical therapeuticsClin.Ther.. 2007;29(9):2107-2119.
Centralising drug review to improve coverage decisions: economic lessons from (and for) Canada. Applied health economics and health policyAppl.Health.Econ.Health.Policy.. 2006;5(2):67-73.
Centralized drug review processes in Australia, Canada, New Zealand, and the United kingdom. Health affairs (Project Hope)Health.Aff.(Millwood). 2006;25(2):337-347.
